Potassium Carbonate → 5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)-1-pyrimidin-5-ylpyridazin-4(1H)-one
反応式
[CH3:1][O:2][C:3]1[C:4]([OH:20])=[C:5]([C:9]2[N:13]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)[N:12]=[CH:11][CH:10]=2)[N:6]=[N:7][CH:8]=1.Br[C:22]1[CH:23]=[N:24][CH:25]=[N:26][CH:27]=1.C(=O)([O-])[O-].[K+].[K+].COC1C2C(=C3C(=CC=2)C(OC)=CC=N3)N=CC=1.C(=O)([O-])O.[Na+]>CS(C)=O.[Cu]I>[CH3:1][O:2][C:3]1[C:4](=[O:20])[C:5]([C:9]2[N:13]([C:14]3[CH:19]=[CH:18][CH:17]=[CH:16][CH:15]=3)[N:12]=[CH:11][CH:10]=2)=[N:6][N:7]([C:22]2[CH:23]=[N:24][CH:25]=[N:26][CH:27]=2)[CH:8]=1参加物
8
反応物 5
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- 110 °C
実験手順
A suspension of 5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4-ol (100 mg), 5-bromopyrimidine (119 mg), potassium carbonate (155 mg), copper(I) iodide (14 mg) and 4,7-dimethoxy-1,10-phenanthroline (20 mg) in DMSO (2 mL) was stirred at 110° C. for 40 hr under an argon atmosphere. To the reaction mixture was added aqueous sodium hydrogen carbonate solution, and the mixture was extracted with ethyl acetate. The extract was dried over anhydrous sodium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by basic silica gel column chromatography (ethyl acetate/methanol), and recrystallized from ethyl acetate/hexane to give the title compound (11 mg).
後処理
- extractionthe mixture was extracted with ethyl acetate
- dry with materialThe extract was dried over anhydrous sodium sulfate
- customthe solvent was evaporated under reduced pressure
- customThe residue was purified by basic silica gel column chromatography (ethyl acetate/methanol)
- customrecrystallized from ethyl acetate/hexane
出典と根拠
- ORDレコード
- ord-03ca3c2730494129871804e15e761e0c
- 出典データセット
- uspto-grants-2015_07
- 特許番号
- US09090586B2
反応ノート
読み込み中…